Kataoka T, Oh-Hashi F, Sakurai Y
Gan. 1984 Jun;75(6):548-56.
Vincristine (VCR) combined with interferon (IFN)-beta suppressed H.Ep #2 cell proliferation more than additively, whereas 6-mercaptopurine combined with IFN-beta suppressed it less than additively. Factors associated with the more-than-additive effect were examined. The enhanced antiproliferation was achieved in HeLa cells as well as H.Ep #2 cells but not in Daudi or M-14 cells, indicating cell dependency of the enhancement. This enhancement was not dependent on the IFN species, including IFN-beta, IFN-alpha (leukocyte), and IFN-alpha (lymphoblastoid), although the cells were variably sensitive to these IFN species. In contrast, the enhance antiproliferation was critically dependent on the species of antineoplastic agents, and was selective to VCR and adriamycin among those tested under the present experimental conditions. The sequential exposure of H.Ep #2 cells to IFN and VCR induced the enhancement but exposure to VCR followed by IFN did not, suggesting that IFN-induced cell modification made the cells more sensitive to VCR. Either IFN or VCR was successfully replaced by colchicine, an antimicrotubule agent, but not by cytochalasin D, an antimicrofilament agent, suggesting the involvement of microtubule modification in the enhanced antiproliferation observed with IFN and VCR.
长春新碱(VCR)与β干扰素(IFN)联合使用对H.Ep #2细胞增殖的抑制作用大于两者单独作用之和,而6-巯基嘌呤与β干扰素联合使用时,其抑制作用小于两者单独作用之和。研究了与超相加效应相关的因素。HeLa细胞和H.Ep #2细胞均出现了增殖抑制增强的现象,但Daudi细胞和M-14细胞未出现,表明这种增强具有细胞依赖性。这种增强不依赖于干扰素种类,包括β干扰素、α干扰素(白细胞)和α干扰素(淋巴母细胞样),尽管细胞对这些干扰素种类的敏感性各不相同。相反,增殖抑制增强关键取决于抗肿瘤药物的种类,在本实验条件下测试的药物中,对长春新碱和阿霉素具有选择性。H.Ep #2细胞先后暴露于干扰素和长春新碱可诱导增殖抑制增强,但先暴露于长春新碱后再暴露于干扰素则不会,这表明干扰素诱导的细胞修饰使细胞对长春新碱更敏感。干扰素或长春新碱均可成功地被秋水仙碱(一种抗微管药物)替代,但不能被细胞松弛素D(一种抗微丝药物)替代,这表明微管修饰参与了干扰素和长春新碱联合使用时观察到的增殖抑制增强现象。